AI Article Synopsis

  • A study involving 41 hips from 38 patients suspected of sepsis focused on the effectiveness of core biopsy in diagnosing the condition.
  • The core biopsy showed high sensitivity (80%) and specificity (100%) for diagnosing infections, but was less effective in confirming resolution of sepsis in patients with a previous septic history.
  • While core biopsy is valuable for assessing failed hip replacements and analyzing periprosthetic tissue, its reliability in confirming that an infection has resolved is limited, particularly for those with past septic complications.

Article Abstract

A prerevision core biopsy from a failed hip joint was performed in 41 hips (38 patients) with a high index of suspicion for sepsis to determine its efficacy in diagnosing sepsis. Seven hips were known septic failures, and core biopsy was undertaken to confirm resolution of sepsis. Forty hips were revised, whereas 1 hip had excision of heterotopic bone. Cultures and permanent histologic sections were obtained during subsequent surgeries, and findings were compared with the results of core biopsy. The commonest organisms isolated were coagulase-negative staphylococci and Propionibacterium acne. In patients without a history of sepsis, core biopsy diagnosed infection with sensitivity of 80%, specificity of 100%, accuracy of 97%, and positive predictive value of 100% using histologic evidence of sepsis at revision as the standard. Core biopsy, however, had low sensitivity and accuracy in establishing resolution of infection in patients with a history of septic failure. Cultures from the aspirate had 44% sensitivity and positive predictive value of 57%. Core biopsy is useful for investigating failed arthroplasties with suspected sepsis. It has advantages of hip aspiration and allows examination of periprosthetic tissue histology. Its role in diagnosing resolution of infection in previously septic failures, however, is limited.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0883-5403(03)00453-4DOI Listing

Publication Analysis

Top Keywords

core biopsy
28
septic failures
8
patients history
8
positive predictive
8
resolution infection
8
biopsy
7
core
6
sepsis
6
role core
4
biopsy diagnosing
4

Similar Publications

Objective: An accurate fine-needle aspiration (FNA) diagnosis of adrenal lesions may be challenging. This study was to investigate roles of imaging guidance, rapid on-site evaluation (ROSE) and additional tissue sampling in FNA diagnosis of adrenal lesions.

Methods: Adrenal FNA cases were retrieved from pathology archive.

View Article and Find Full Text PDF

Introduction: Limited information exists on next-generation sequencing (NGS) success for lung tumors of 30 mm or less. We aimed to compare NGS success rates across biopsy techniques for these tumors, assess DNA sequencing quality, and verify reliability against surgical resection results.

Methods: We used data from the Initiative for Early Lung Cancer Research on Treatment study, including patients with lung tumors measuring 30 mm or less who had surgery and NGS on biopsies since 2016.

View Article and Find Full Text PDF

Background: Atypical ductal hyperplasia (ADH) is a benign proliferative breast lesion. Surgical excision of ADH is often recommended to rule out underlying malignant disease.

Objective: The aim of this study was to evaluate the trends in ADH upgrade rates over time and identify the impact of magnetic resonance imaging (MRI) use on upgrade rates.

View Article and Find Full Text PDF

Background: Ductal carcinoma in situ (DCIS) is overtreated, in part because of inability to predict which DCIS cases diagnosed at core needle biopsy (CNB) will be upstaged at excision. This study aimed to determine whether quantitative magnetic resonance imaging (MRI) features can identify DCIS at risk of upstaging to invasive cancer.

Methods: This prospective observational clinical trial analyzed women with a diagnosis of DCIS on CNB.

View Article and Find Full Text PDF

Extracellular vesicles (EVs) are emerging as crucial biomarkers in cancer diagnostics and therapeutics with their heterogeneity presenting both challenges and opportunities in prostate cancer research. However, existing methods for isolating and characterizing EV subtypes have been limited by inefficient separation and inadequate proteomic analysis. Here we show an optimized centrifugal microfluidic device, Exodisc, that efficiently isolates large quantities of EV subtypes from particle-enriched medium, enabling comprehensive proteomic analysis of small (EV-S, 20-200 nm) and large (EV-L, >200 nm) EVs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!